| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association Between PD-L1 Score and the Outcomes of Consolidation Durvalumab in a Large Nationwide Series of Patients With Stage III NSCLC Treated With Chemoradiotherapy
|
Damhuis, Ronald
|
|
|
25 |
8 |
p. 683-689
|
artikel
|
| 2 |
Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung Cancer
|
Meyer, May-Lucie
|
|
|
25 |
8 |
p. e482-e486.e3
|
artikel
|
| 3 |
Comments on “Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or PD-L1 Inhibitors in Advanced Lung Squamous Cell Carcinoma”
|
Huang, Jie
|
|
|
25 |
8 |
p. e446-e447
|
artikel
|
| 4 |
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations
|
Lara, Matthew S.
|
|
|
25 |
8 |
p. 732-737
|
artikel
|
| 5 |
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer
|
Bestvina, Christine M.
|
|
|
25 |
8 |
p. e448-e452
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
25 |
8 |
p. A1
|
artikel
|
| 7 |
Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM)
|
Enrico, Diego
|
|
|
25 |
8 |
p. 723-731.e2
|
artikel
|
| 8 |
Efficacy of Prophylactic Cranial Irradiation in Early to Mid-stage Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging
|
Liu, Jianjiang
|
|
|
25 |
8 |
p. 690-698.e2
|
artikel
|
| 9 |
Evaluating Safety and Clinical Activity of Front-line Treatment with Cadonilimab plus Chemotherapy in Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring STK11 Genetic Aberration: A Protocol of Phase II Study
|
Jiang, Huixin
|
|
|
25 |
8 |
p. e393-e396
|
artikel
|
| 10 |
Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients
|
Jha, Prerana
|
|
|
25 |
8 |
p. e420-e430.e20
|
artikel
|
| 11 |
Letter to the Editor in Response to “Adherence to Annual Lung Cancer Screening in a Centralized Academic Program”
|
Wu, Julie
|
|
|
25 |
8 |
p. e457-e458
|
artikel
|
| 12 |
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC
|
Leonetti, Alessandro
|
|
|
25 |
8 |
p. e436-e445.e9
|
artikel
|
| 13 |
Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR Inhibition
|
Acker, Fabian
|
|
|
25 |
8 |
p. 672-682.e5
|
artikel
|
| 14 |
Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies
|
Smith, Margaret R.
|
|
|
25 |
8 |
p. e379-e388
|
artikel
|
| 15 |
Osimertinib-Related QTc Prolongation: Real-World Incidence and Impact of Drug Dosing on Recurrence Risk
|
Chen, Olivia H.
|
|
|
25 |
8 |
p. 738-743.e2
|
artikel
|
| 16 |
Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy
|
Huet, C.
|
|
|
25 |
8 |
p. e402-e410.e3
|
artikel
|
| 17 |
Physical Exercise During Neoadjuvant Treatments for Non-Small Cell Lung Cancer: The Time is Coming
|
Avancini, Alice
|
|
|
25 |
8 |
p. e431-e435
|
artikel
|
| 18 |
RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer
|
Reyes, Amanda
|
|
|
25 |
8 |
p. e411-e419
|
artikel
|
| 19 |
Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study
|
Kakiuchi, Yosuke
|
|
|
25 |
8 |
p. 661-671.e7
|
artikel
|
| 20 |
Response to Editor: Commentary on “Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or PD-L1 Inhibitors in Advanced Lung Squamous Cell Carcinoma”
|
Chen, Qin
|
|
|
25 |
8 |
p. e479-e481
|
artikel
|
| 21 |
Single-drug Chemotherapy Plus Immunotherapy as First-line Treatment for Stage Ⅳ Non-small Cell Lung Cancer Elderly Patients: A Phase II Clinical Trial UNICORN Study
|
Ma, Jia
|
|
|
25 |
8 |
p. e389-e392
|
artikel
|
| 22 |
Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study
|
Graber-Naidich, Anna
|
|
|
25 |
8 |
p. 705-711.e7
|
artikel
|
| 23 |
Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator
|
Tissera, Sanuki
|
|
|
25 |
8 |
p. e466-e478
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
25 |
8 |
p. A3-A7
|
artikel
|
| 25 |
The EXcellenT Trial: Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment
|
Bennati, Chiara
|
|
|
25 |
8 |
p. e397-e401
|
artikel
|
| 26 |
Understanding the Social Risk Factors That Avert Equitable Lung Cancer Care
|
Kapp, Christopher M.
|
|
|
25 |
8 |
p. 699-704
|
artikel
|
| 27 |
Untapping the Prognostic Value of Patient-Generated Health Data in Locally Advanced Non-small Cell Lung Cancer
|
Ohri, Nitin
|
|
|
25 |
8 |
p. e459-e465.e1
|
artikel
|
| 28 |
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer
|
Watson, Alexander S.
|
|
|
25 |
8 |
p. 712-722.e1
|
artikel
|
| 29 |
Video Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Population: A Multicenter Retrospective Cohort Study
|
Qasim, Rameez
|
|
|
25 |
8 |
p. e453-e454
|
artikel
|
| 30 |
“Video Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Population: A Multicenter Retrospective Cohort Study”
|
Pan, Hanbo
|
|
|
25 |
8 |
p. e455-e456
|
artikel
|
Tijdschrift beschrijving